The Importance of COVID-19 Prevention and Containment in Hemodialysis Unit [0.03%]
血液透析中心新型冠状病毒肺炎的预防与控制的重要性分析
Michael Anthonius Lim,Raymond Pranata
Michael Anthonius Lim
Comparison of Vancomycin Pharmacokinetics in Cystic Fibrosis Patients Pre and Post-lung Transplant [0.03%]
囊性纤维化患者肺移植前后面抗菌药物万古霉素的药代动力学对比研究
Shannon White,Colleen Sakon,Linda Fitzgerald et al.
Shannon White et al.
Background: Vancomycin is commonly used to treat acute cystic fibrosis (CF) exacerbations associated with methicillin-resistant Staphylococcus aureus (MRSA). Multiple studies have demonstrated pharmacokinetic differences ...
Bevacizumab-Induced Pneumonitis in a Patient With Metastatic Colon Cancer: A Case Report [0.03%]
贝伐单抗致肺毒性反应1例报告
Sami Pervaiz,Sylvester Homsy,Naureen Narula et al.
Sami Pervaiz et al.
Bevacizumab is a vascular endothelial growth factor-directed humanized monoclonal antibody used to treat many types of cancer and some eye diseases. Due to inhibition of angiogenesis, many adverse reactions such as bowel necrosis, nasal sep...
Patient and Physician Perspectives on Systemic Sclerosis-Associated Interstitial Lung Disease [0.03%]
系统性硬化症相关间质性肺病的患者和医师观点
Tariq J Cheema,Meilin Young,Erica Rabold et al.
Tariq J Cheema et al.
Systemic sclerosis-associated interstitial lung disease is challenging to diagnose and treat. Patients and physicians can perceive the disease differently and have different views on its management. Communication issues between them can lea...
Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies [0.03%]
有关空气释放通气的证据、理论益处及替代调节策略综述
Andrew S Fredericks,Matthew P Bunker,Louise A Gliga et al.
Andrew S Fredericks et al.
Objective: To review the theoretical benefits of airway pressure release ventilation (APRV), summarize the evidence for its use in clinical practice, and discuss different titration strategies. ...
Use of Pulse Pressure Variation as Predictor of Fluid Responsiveness in Patients Ventilated With Low Tidal Volume: A Systematic Review and Meta-Analysis [0.03%]
低潮气量通气患者中脉压变异用于预测液体反应性的系统评价和 meta 分析
Jorge Iván Alvarado Sánchez,Juan Daniel Caicedo Ruiz,Juan José Diaztagle Fernández et al.
Jorge Iván Alvarado Sánchez et al.
Introduction: Pulse pressure variation (PPV) has been shown to be useful to predict fluid responsiveness in patients ventilated at tidal volume (Vt) >8 mL kg-1. Nevertheless, most conditions in critical care force to use ...
Characteristics and Outcomes of Severe ARDS Patients Receiving ECMO in Southern Thailand [0.03%]
泰国南部严重ARDS患者接受ECMO治疗的特点和结局
Nawaporn Assanangkornchai,Polathep Vichitkunakorn,Rungsun Bhurayanontachai
Nawaporn Assanangkornchai
Extracorporeal membrane oxygenation (ECMO) is a treatment option considered for acute respiratory distress syndrome (ARDS) patients who are refractory to conventional treatments. However, treatment with ECMO has not shown significant reduct...
Histological Transformation to Small Cell Carcinoma of an Adenosquamous Carcinoma of the Lung With Epidermal Growth Factor Receptor Mutation in Exons 20 and 21 After Treatment With Erlotinib: Case Report [0.03%]
厄洛替尼治疗后EGFR外显子20和21突变型肺腺鳞癌向小细胞癌的组织学转化：病例报告
Liliana Fernández-Trujillo,Laura Tapia,Marcela Vallejo et al.
Liliana Fernández-Trujillo et al.
Lung carcinoma currently represents 1 of the leading causes of death from cancer worldwide and regionally. The molecular identification of sensitive mutations of targeted treatment have changed the strategies of pharmacologic management in ...
Assessment of Pleural Effusion and Small Pleural Drain Insertion by Resident Doctors in an Intensive Care Unit: An Observational Study [0.03%]
一项观察性研究：重症监护病房住院医评估胸腔积液并置入小胸管的能力
Luigi Vetrugno,Giovanni M Guadagnin,Federico Barbariol et al.
Luigi Vetrugno et al.
Small-bore pleural drainage device insertion has become a first-line therapy for the treatment of pleural effusions (PLEFF) in the intensive care unit; however, no data are available regarding the performance of resident doctors in the exec...
Role of Deleterious Rare Alleles for Acute-Onset Diffuse Interstitial Lung Disease in Collagen Diseases [0.03%]
胶原病急性发散性间质性肺疾病的有害罕见等位基因的作用
Hiroshi Furukawa,Shomi Oka,Kota Shimada et al.
Hiroshi Furukawa et al.
Objective: Acute-onset diffuse interstitial lung disease (AoDILD) includes acute exacerbation of interstitial lung disease (ILD), drug-induced ILD, and Pneumocystis pneumonia in collagen diseases patients. As AoDILD cause...